Table 3.
Meta-analysis findings for estimated Xpert and microscopy sensitivity and specificity against the reference standards
| Number of studies (number of children) | Pooled and predicted median sensitivity (pooled 95% credible interval; predicted 95% credible interval) | Pooled and predicted median specificity (pooled 95% credible interval; predicted 95% credible interval) | |
|---|---|---|---|
| Xpert against culture | |||
| Expectorated and induced sputum | 12 (2380)12,14–16,18–20,22,23,25*† | 62% (51–73; 30–87) | 98% (97–99; 90–100) |
| Gastric lavage | 7 (1319)12–14,17,20,21† | 66% (51–81; 33–91) | 98% (96–99; 91–100) |
| Xpert against culture-negative and started on ATT | |||
| Expectorated and induced sputum | 8 (1512)14–16,18,19,23,25* | 2% (1–3; 0–6) | 100% (99–100; 99–100) |
| Smear microscopy against culture | |||
| Expectorated and induced sputum | 12 (2380)12,14–16,18–20,22,23,25*† | 26% (14–39; 4–69) | 100% (99–100; 94–100) |
| Gastric lavage | 7 (1319)12–14,17,20,21† | 22% (12–35; 6–51) | 99% (97–100; 93–100) |
Includes published and one unpublished study. ATT=antituberculosis treatment.
Expectorated and induced sputum cohorts from reference 16 included as separate studies.
Also includes data from Walters E, Desmond Tutu TB Centre, personal communication.